BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25597570)

  • 1. Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
    Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G
    J Am Geriatr Soc; 2015 Jan; 63(1):179-80. PubMed ID: 25597570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypomagnesemia induced by proton pump inhibitors, diarrhea, and lactose intolerance].
    Cano Megías M; Alvarez Santirso R; Iglesias Lozano P; Carrasco De La Fuente M; Pérez López G
    Endocrinol Nutr; 2011 Dec; 58(10):550-4. PubMed ID: 21764396
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypomagnesemia and hypoparathyroidism induced by omeprazole.
    Rodríguez Ortega P; Rebollo Pérez I; Laínez López M; Roldán Mayorga E; Hernández Lavado R; Creagh Cerquera R
    Endocrinol Nutr; 2013 Mar; 60(3):156-7. PubMed ID: 22627012
    [No Abstract]   [Full Text] [Related]  

  • 4. In brief: PPI's and hypomagnesemia.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drugs affecting serum magnesium concentration].
    Kawamura Y
    Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
    Piezzi V; Kullak-Ublick GA; Glisenti P
    Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated hypomagnesemia in a patient treated with capecitabine.
    Rajapakse S; Rodrigo C; Rajapakse AC
    J Oncol Pharm Pract; 2013 Sep; 19(3):254-6. PubMed ID: 22948887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Review: UPDATE on magnesium metabolism].
    Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypomagnesemia and electrolyte disturbances induced by proton pump inhibitors.
    Turnock M; Pagnoux C; Shore K
    J Dig Dis; 2014 Aug; 15(8):459-62. PubMed ID: 24798177
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
    Cheminet G; Clain G; Jannot AS; Ranque B; Passeron A; Michon A; De Luna G; Diehl JL; Oudard S; Cellier C; Karras A; Vedié B; Prot-Bertoye C; Pouchot J; Arlet JB
    Intern Emerg Med; 2018 Dec; 13(8):1201-1209. PubMed ID: 29951810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer].
    Inose R; Takahashi K; Nishikawa T; Nagayama K
    Yakugaku Zasshi; 2015; 135(12):1403-7. PubMed ID: 26632157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats.
    Chamniansawat S; Kampuang N; Suksridechacin N; Thongon N
    Anat Sci Int; 2021 Jan; 96(1):142-156. PubMed ID: 32931001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone].
    Yamamoto Y; Watanabe K; Matsushita H; Tsukiyama I; Matsuura K; Wakatsuki A
    Yakugaku Zasshi; 2017; 137(1):79-82. PubMed ID: 28049899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.
    Bégin MJ; Ste-Marie LG; Coupal L; Ethier J; Räkel A
    J Bone Miner Res; 2018 Aug; 33(8):1444-1449. PubMed ID: 29637622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.
    Koulouridis I; Alfayez M; Tighiouart H; Madias NE; Kent DM; Paulus JK; Jaber BL
    Am J Kidney Dis; 2013 Oct; 62(4):730-7. PubMed ID: 23664547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.